Current Report Filing (8-k)
April 05 2017 - 6:05AM
Edgar (US Regulatory)
Item 7.01 Regulation FD Disclosure
On April 4, 2017, ITUS Corporation (the "Company") issued a press release announcing the closing of its rights offering. The rights offering was made pursuant to the Company's effective registration statement on Form S-3 (Reg. No. 333-206782) on file with the U.S. Securities and Exchange Commission (the "SEC"). The Company raised gross proceeds of approximately $4.7 million before payment of dealer manager fee and other expenses, through the issuance of 1,989,207 shares of common stock in the rights offering. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
In accordance with General Instruction B.2 of Form 8-K, the information contained in Exhibit 99.1 furnished as an exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, is not subject to the liabilities of that section, and shall not be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
The following exhibits are filed with this Current Report on Form 8-K:
Exhibit No. Description
99.1 Press Release dated April 4, 2017
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: April 4, 2017
|
ITUS CORPORATION
|
|
| |
|
By:
|
/s/ Robert A. Berman
|
|
|
Name: Robert A. Berman
|
|
|
Title: President and Chief Executive Officer
|
3
Anixa Biosciences (NASDAQ:ANIX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anixa Biosciences (NASDAQ:ANIX)
Historical Stock Chart
From Apr 2023 to Apr 2024